MOLECULAR CHARACTERIZATION OF MUSCARINIC ACH RECEPTORS
MOLECULAR CHARACTERIZATION OF MUSCARINIC ACH RECEPTORS
批准号:
3402164
负责人:
WILLIAM L KLEIN
金额:
$10.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-23 至 1988-08-31
关键词:
acetylcholine affinity chromatography autoradiography chemical binding electron microscopy gel electrophoresis genetic library genetic translation histochemistry /cytochemistry hybridomas immunochemistry ligands molecular weight monoclonal antibody neural information processing neurochemistry synapses
中文摘要
这项工作的长期目标是了解信号转导如何
英文摘要
The long-range goal of this work is to understand how signal transduction
is established and maintained at CNS cholinergic synapses; its focus is on
the biochemistry, development and cellular regulation of muscarinic ACh
receptors. These receptors mediate a large proportion of CNS cholinergic
signaling, have been implicated in many behaviorally and clinically
significant phenomena and show a broad spectrum of transductional and
regulatory responses. At present, it appears most appropriate to isolate
and begin characterizing receptor system proteins and to generate receptor
specific antibodies for studies of muscarinic cell and developmental
biology. The following three aims have therefore been chosen:
AIM #1--To generate a library of muscarinic receptor-specific monoclonal
antibodies. Partially purified (250-fold) bovine brain receptors will be
used for antibody induction using a combination of methods already tested
for their effectiveness. Binding assays and western blots will be used in
testing antibody specificity.
AIM #2--To purify and begin characterization of receptor molecules.
Immunoaffinity chromatography will be added to tested separations based on
subcellular fractionation, hydrophobicity, charge, molecular weight and
specific glycosylation. 2D-Gel, sedimentation equilibrium and N-terminal
analyses will be used in testing purity. The ligand specificity, number of
subunits, number of binding sites, and overall amino acid composition of
the purified molecules will be assessed.
AIM #3--To localize receptors as a function of synaptic development,
post-translational modification, and cholinergic stimulation. The
monoclonal antibodies obtained above will be used to localize receptors on
avian retina neurons at the subcellular and ultrastructural levels. A
novel approach employing isolation of differentiated neurons and HVEM whole
mount analysis will be used.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Physiological role of naturally-occuring amyloid beta oligomers
-
批准号:9759747
-
项目类别:
-
资助金额:$19.29万
-
财政年份:2018
-
负责人:WILLIAM L KLEIN
-
依托单位:
Development of a non-fibrillic amyloid-beta oligomer selective positron emission tomography imaging diagnostic for Alzheimer.
-
批准号:9202960
-
项目类别:
-
资助金额:$22.22万
-
财政年份:2016
-
负责人:WILLIAM L KLEIN
-
依托单位:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
-
批准号:8842908
-
项目类别:
-
资助金额:$18.73万
-
财政年份:2014
-
负责人:WILLIAM L KLEIN
-
依托单位:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
-
批准号:8683797
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2014
-
负责人:WILLIAM L KLEIN
-
依托单位:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
-
批准号:8548221
-
项目类别:
-
资助金额:$18.44万
-
财政年份:2012
-
负责人:WILLIAM L KLEIN
-
依托单位:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
-
批准号:8446087
-
项目类别:
-
资助金额:$24.74万
-
财政年份:2012
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7615522
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7184209
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7470605
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimers Disease pathology
-
批准号:6678227
-
项目类别:
-
资助金额:$33.05万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7805554
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs)in Alzheimers Disease pathology
-
批准号:6931646
-
项目类别:
-
资助金额:$34.61万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7467169
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs)in Alzheimers Disease pathology
-
批准号:6795925
-
项目类别:
-
资助金额:$34.62万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7595791
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6233462
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6615732
-
项目类别:
-
资助金额:$29.23万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6532552
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
MORPHOGENIC SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2703069
-
项目类别:
-
资助金额:$19.22万
-
财政年份:1996
-
负责人:WILLIAM L KLEIN
-
依托单位:
MORPHOGENIC SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2273680
-
项目类别:
-
资助金额:$18.86万
-
财政年份:1996
-
负责人:WILLIAM L KLEIN
-
依托单位:
海外基金